- Saravanan S, Rengaswamy R, Narula G, Bakhshi S, Seth R, Das N, Gogoi MP, Banavali S, Srinivasan P, Das G, Balaji TK, Krishnan S, Saha V, Ramshankar V, Radhakrishnan V. PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia. JCO Clin Cancer Inform. 2026 Jan;10:e2500222.
- Das P, Das N, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, Seth R, Tembhare P, Singh Sachdeva MU, Chopra A, Sundersingh S, Das S, Gogoi MP, Parihar M, Bhattacharya R, Banavali S, Saha V, Krishnan S. Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022). Lancet Reg Health Southeast Asia. 2026 Jun 7;50:100788.
- Uppuluri R, Kalra M, Katewa S, Gunasekaran V, Radhakrishnan N, Dhamne C, Siddaiahgari S, Raj R. Prospective Collaborative Study for Pulse Dexamethasone and Lenalidomide in Relapsed/Refractory Langerhans Cell Histiocytosis (LENDEX-LCH Study): INPHOG-HIST-19-03 (CTRI/2020/07/026937). Pediatr Blood Cancer. 2026 May;73(5):e70217.
- Seth R, Kapoor G, Moulik NR, Kaushik P, Verma N, Mahajan A, T P, Radhakrishnan N, Raj R, Singh A, Sharma S, Radhakrishnan V, Rani S, Bhattacharyya P, Krishnan Y, Mandal P, Rahiman EA, Jain P, Sahoo D, Mohapatra D, Das G, Gupta V, Singh G, Kakkar S, Singh A, Prabhakar P, Kumar Ar A, Meena JP, Gupta AK, Malhotra P, Kumar C, Didel S, Arora SK, Patil V, Prakash A, Kanvinde P, Prasad M, Chandra J, Kurkure P, Arora R. Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort: a multicentre study (2016-2024). Lancet Reg Health Southeast Asia. 2026 Feb 5;45:100727.
- Radhakrishnan V, Srinivasan P, Das G, Bakhshi S, Mahajan A, Ganesan P, Thiruvengadam Kothandan B, Arora RS, Parmpalli Manjunath S, Ganguly S, Pushpam D, Bansal M, Keerthivasagam S, Sharma A, Goel A, Begum M, Khan A, Rajaraman S. Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD). J Clin Oncol. 2026 Sep;44(25):2379-2389.
- Reddy JM, Krishnan Y, Patil V, Arora RS, Bhattacharya A, Guru F, Kakkar S, Kalra M, Mahajan A, Mudaliar S, Radhakrishnan V, Raj R, Rani S, Patel N, Modak S, Kanwar VS. Treatment and Outcome of Children With Neuroblastoma in India: Report From the InPOG-NB-18-01 India Neuroblastoma Registration Study. Pediatr Blood Cancer. 2026 Sep;73(9):e70431.
- Gogoi MP, Das P, Das N, Das S, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, Seth R, Tembhare P, Singh Sachdeva MU, Chopra A, Sundersingh S, Parihar M, Bhattacharya R, Banavali S, Saha V, Krishnan S. Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India. Lancet Reg Health Southeast Asia. 2025 May 13;37:100593.
- Radhakrishnan V, Jothi A, Mary R, Veeraiah S, Sudhakar R, Selvam P, Kothandan BT, Santana V, Steliarova-Foucher E, Bhakta N, Rajaraman S. Assessment of Barriers and Enablers for Implementing a Population-Based Childhood Cancer Registry in Chennai, India. Pediatr Blood Cancer. 2025 Mar;72(3):e31500. doi: 10.1002/pbc.31500. Epub 2024 Dec 31. Erratum in: Pediatr Blood Cancer. 2025 Jun;72(6):e31652.
- Khan MS, Tomizawa D, Zheng H, Saha V, Ariffin H, Hori H, Arora RS, Tamamyan G, Aisyi M, Kurkure P, Agarwal B, Yu AL, Dalvi R, Kirgizov K, Chen BW, Seksarn P, Nakagawara A, Chan GCF, Arakawa A, Gao Y, Krishnan S, Yeoh AEJ, Luo XQ, Zhu XF, Manabe A, Li CK. Landscape of paediatric oncology clinical trials in Asia. EClinicalMedicine. 2025 Nov 4;89:103555.
- Chantada GU, Villarroel MI, Israels T. The impact of the SIOP Programme for advancing research capacity on global childhood cancer research. Cancer Control. 2025;1:92-7.
- Das S, Meel R, Mahajan A, Bansal R, Reddy VA, Prasad S, Lomi N, Bakhshi S, Kashyap S, Bhattacharjee K, Tripathy D, Verma N, Singh U, Shah PK, Ali MS, Ghosh A, Singh A, Honavar SG. Lag time for diagnosis and treatment in 1120 retinoblastoma children: Analysis from InPOG-RB-19-01. Indian J Ophthalmol. 2025 Aug 1;73(8):1124-1131.
- Siddaiahgari SR, Vaddadi S, Bandi V, Trivedi D, Bhattacharya A, Radhakrishnan V, Patil V, Mahajan A, Kapoor G, Mishra S, Raj R, Uppuluri R, Prakash A, Scott J, Jayaram D, Kurkure P, Misra R, Mehdi I, Shekhar S, Bafna V, M V A, Bhat V, Krishnan Y, Arora RS. Patterns of Care and Survival of Wilms Tumor in Children in India: A Retrospective Multicentric INPHOG Study. Pediatr Blood Cancer. 2025 Sep;72(9):e31871.
- Kalra M, Bakhshi S, Singh M, Seth R, Verma N, Jain S, Radhakrishnan V, Mandal P, Mahajan A, Arora RS, Dinand V, Kapoor G, Sajid M, Kumar R, Taluja A, Mallick S, Chandra J. Response assessment by positron emission tomography-computed tomography as compared with contrast-enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low- and middle-income countries. Pediatr Blood Cancer. 2023 Feb;70(2):e30091.
- Banwait DK, Arora PR, Mahajan A, Dinand V, Jain S, Kalra M, Chandra J, Arora RS. Barriers to Accessing Fertility Preservation in Adolescents with Hodgkin Lymphoma in India. Pediatr Hematol Oncol. 2024;41(2):163-168.
- Li CK, Kurkure P, Arora RS, Chen BW, Kirgizov K, Okamoto Y, Seksarn P, Tang Y, Yoo KH, Agarwal B, Chan GCF, Dalvi R, Hori H, Khan MS, Yu A, Nakagawara A. Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group. JCO Glob Oncol. 2023 Sep;9:e2300153.
- Raj R, Uppuluri R, Parambil B, Dhariwal N, Totadri S, Mathew LG, Radhakrishnan V, Charan A, Yadav SP, Mahajan A, Mudaliar S, Sharma R, Manglani M, Kharya G, Verma N, Arora R, Ghara N, KS R, Radhakrishnan N, Iyer N, Mehta P, Singh A, Patel S, John J, Bhat S, Badiger S, Siddaiahgari S, Kakkar S, Scott J, Jayaraman D, Srinivasan A, Krishnan Y, Sonamani N, Misra R, Bafna V, Seth R, Kutty PK, Kanakia S, Rao V, Prakash A, Bharadwaj V, Chinnasamy G; Indian Pediatric Oncology Group (InPOG). Outcomes of COVID-19 in children with cancer – Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India. Pediatric Hematology Oncology Journal. 2022 Jun;7(2):34–7.
- Mahajan A, Bakhshi S, Singh M, Seth R, Verma N, Jain S, Radhakrishnan V, Mandal P, Arora RS, Dinand V, Kalra M, Kapoor G, Sajid M, Kumar R, Mallick S, Taluja A, Chandra J. Empirical Antitubercular Treatment for Lymphadenopathy: Are We Missing Lymphoma? Indian J Pediatr. 2022 Jun 23.
- Mahajan A, Bakhshi S, Seth R, Verma N, Mandal P, Singh M, Jain S, Radhakrishnan V, Kanvinde S, Arora RS, Dinand V, Kalra M, Taluja A, Mallick S, Kumar R, Chandra J. Hodgkin Lymphoma in Children Under 5 Years: Do They Behave Differently? J Pediatr Hematol Oncol. 2022 May 1;44(4):186-190.
- Sharma J, Mahajan A, Bakhshi S, Patil V, Verma N, Radhakrishnan V, Singh A, Kayal S, Seth R, Pushpam D, Arora RS. The impact of COVID-19 pandemic on access to treatment for children with cancer in India and treating center practices. Cancer. 2022 Feb 1;128(3),579-86.
- Das N, Banavali S, Bakhshi S, Trehan A, Radhakrishnan V, Seth R, Arora B, Narula G, Sinha S, Roy P, Gogoi MP, Chatterjee S, Abraham B, Das P, Saha V, Krishnan S. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India. Trials. 2022 Jan 31;23(1):102.
- Rahiman EA, Bakhshi S, Deepam Pushpam, Ramamoorthy J, Das A, Ghara N, Kalra M, Kapoor G, Meena JP, Siddaigarhi S, Thulkar S, Sharma MC, Srinivasan R, Trehan A. Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study). Pediatr Hematol Oncol. 2022 Jan 3:1-15.
- Kalra M, Bakhshi S, Singh M, Seth R, Verma N, Jain S, Radhakrishnan V, Mandal P, Mahajan A, Arora RS, Dinand V, Kapoor G, Sajid M, Kumar R, Taluja A, Mallick S, Chandra J. Response assessment by positron emission tomography-computed tomography as compared with contrast-enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low- and middle-income countries. Pediatr Blood Cancer. 2022 Nov 21:e30091.
- Jain S, Bakhshi S, Seth R, Verma N, Singh M, Mahajan A, Radhakrishnan V, Mandal P, Arora RS, Dinand V, Kalra M, Sharma A, Chandra J. Risk based and response adapted radiation therapy for children and adolescents with newly diagnosed advanced Hodgkin lymphoma treated with ABVD chemotherapy: A report from the Indian Pediatric Oncology Group study InPOG-HL-15-01. Leuk Lymphoma 2021 Dec 9:1-8.
- Mahajan A, Singh M, Bakhshi S, Jain S, Seth R, Verma N, Kumar A, Radhakrishnan V, Mandal P, Kapoor G, Arora RS, Dinand V, Kalra M, Sharma A, Phulkar S, Arora A, Chandra J. Treating Early Stage Hodgkin Lymphoma in resource limited settings: InPOG-HL-15-01 Experience. Pediatric Blood & Cancer. 2021 Jul 22:e29219.
- Arora RS, Raj R, Mahajan A, Radhakrishnan N, Chinnaswamy G, Banavali S. Collaborative cancer research: progress report from the Indian Pediatric Oncology Group. Lancet Child Adolesc Health. 2021 Apr;5(4):239-240.
- Faruqui N, Bernays S, Martiniuk A, Abimbola S, Arora R, Lowe J, Denburg A, Joshi R, Access to care for childhood cancers in India: perspectives of health care providers and the implications for Universal Health Coverage. BMC Public Health 2020 Dec;20(1):1-1.
- Arora RS, Mahajan A, Dinand V, Kalra M, Jain S, Taluja A, Mandal P, Chandra J. InPOG-HL-15-01 - Challenges and Lessons Learnt in Setting up the First Collaborative Multicentre Prospective Clinical Trial in Childhood Cancer in India. Pediatric Hematology Oncology J 2020. Oct 1;5(4):166-70.
- Pediatric Hematology Oncology Chapter of Indian Academy of Pediatrics (PHO IAP), Indian Pediatric Oncology Group (InPOG), Cankids Kidscan representing Civil Society & Patient Groups. WHO Global Initiative for Childhood Cancer – India Responds Pediatric Hematology Oncology J 2020. Oct 1;5(4):145-50.
- Faruqui N, Joshi R, Martiniuk A, Lowe J, Arora R, Anis H, Kalra M, Bakhshi S, Mishra A, Santa A, Sinha S, Siddaiahgari S, Seth R, Bernays S. A health care labyrinth: perspectives of caregivers on the journey to accessing timely cancer diagnosis and treatment for children in India. BMC Public Health. 2019 Dec 2;19(1):1613.
Donate Now